# The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

> **NCT02234804** · NA · UNKNOWN · sponsor: **Aarhus University Hospital Skejby** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Xience Prime Stent
- **DEVICE:** Medtronic Resolute Integrity stent
- **PROCEDURE:** Angiography
- **PROCEDURE:** OCT

## Key facts

- **NCT ID:** NCT02234804
- **Lead sponsor:** Aarhus University Hospital Skejby
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234804, "The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02234804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*